In this study we applied differential gene expression analysis to exfoliated human urothelia obtained from patients of known bladder disease status. Selected targets from the microarray data were validated in an independent set of samples using a quantitative PCR approach.
A candidate molecular biomarker panel for the detection of bladder cancer.
Specimen part, Disease
View Samples